SCHEMBL2015194

SCHEMBL2015194

CC(=O)c1c(F)c(Cl)c(C)c(N)c1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HSD17B10 Q99714 3/20 0.39
TP53 P04637 1/20 0.39
FABP3 P05413 1/20 0.38
FABP4 P15090 1/20 0.38
CSF1R P07333 1/20 0.38
FGFR1 P11362 1/20 0.38
FLT1 P17948 1/20 0.38
KDR P35968 1/20 0.38
CSNK1A1 P48729 1/20 0.38
CDK8 P49336 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
CDK5 Q00535 1/20 0.38
PRKCQ Q04759 1/20 0.38
LRRK2 Q5S007 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
DYRK1B Q9Y463 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015196 0.72 AR (0.33) KDM4ESMN1; SMN2HSD17B10FABP3FABP4
SCHEMBL18817131 0.71 KDM4E (0.41) KDM4EKMT2ASMN1; SMN2HSD17B10FABP3
SCHEMBL21486187 0.70 TRPM8 (0.37) SMN1; SMN2ALDH1A1
SCHEMBL25615395 0.67 PDE4A (0.38) KDM4EKMT2ASMN1; SMN2HSD17B10CDK8
SCHEMBL25614912 0.67 L3MBTL1 (0.39) KDM4EKMT2ASMN1; SMN2HSD17B10CDK8
SCHEMBL28115563 0.67 KMT2A (0.37) KDM4EKMT2ASMN1; SMN2HSD17B10TP53
SCHEMBL1666394 0.66 SMN1; SMN2 (0.52) KDM4EKMT2ASMN1; SMN2HSD17B10MAPT
SCHEMBL1666977 0.66 SMN1; SMN2 (0.50) KDM4EKMT2ASMN1; SMN2HSD17B10MAPT
SCHEMBL25428412 0.64 AKT2 (0.50) KDM4EKMT2ASMN1; SMN2HSD17B10TP53
SCHEMBL28211222 0.64 BRD4 (0.45) KDM4EKMT2ASMN1; SMN2HSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655374-A1 N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS Incyte Corporation (US) 2013-10-30 EP disclosed
WO-2012087881-A1 N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2012-06-28 WO disclosed
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed